We are looking for young people aged 2 to 17 years to join a clinical research study to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or IBD (including associated symptoms such as rectal bleeding, loss of appetite, rectal pain, chronic fatigue and/or eye pain), consider one of our ICD and UC clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.
Your child may be eligible to take part in the ICD and UC clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrolling for a limited time.
